The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Drug Targeting to the Brain
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–208 of 208
Zhu, C., Zhang, Y., Zhang, Y., Li, J. Y., Boado, R. J., & Pardridge, W. M. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.575 · Cited by 29
Self-citationWang, X., Kong, L., Zhang, G., Sun, M., & Geller, A. I. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.05.029 · Cited by 26
Vezzani, A. (2004) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7597.2004.43001.x · Cited by 24
Site‐directed mutagenesis of rabbit LAT1 at amino acids 219 and 234
Boado, R. J., Li, J. Y., & Pardridge, W. M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01622.x · Cited by 24
Self-citationLiposomal and Viral Vectors for Gene Therapy of the Central Nervous System
de Lima, M. C. P., da Cruz, M. T. G., Cardoso, A. L., Simões, S., & de Almeida, L. P. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007054546144 · Cited by 23
INFILTRATION OF INDIA INK FROM SUBARACHNOID SPACE TO NASAL MUCOSA ALONG OLFACTORY NERVES IN RABBITS
Yamazumi, H. (1989) · Nippon Jibiinkoka Gakkai Kaiho · doi:10.3950/jibiinkoka.92.608 · Cited by 16
Suzuki, T., Zhang, Y., Zhang, Y., Schlachetzki, F., & Pardridge, W. M. (2004) · Molecular Imaging · doi:10.1162/1535350042973535 · Cited by 14
Self-citationTerasaki, T. (1998) · Cambridge University Press eBooks · doi:10.1017/cbo9780511570216.003 · Cited by 8
Cited by
Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609
“However, in recent years, only a minor number of brain-directed pharmaceuticals have reached the market (3–5%) since most of them were incapable of crossing the BBB in vivo [38].”
BackgroundApproaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 802
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
The blood-brain barrier: an engineering perspective
Wong, A. D., Ye, M., Levy, A. F., Rothstein, J. D., Bergles, D. E., & Searson, P. C. (2013) · Frontiers in Neuroengineering · doi:10.3389/fneng.2013.00007 · Cited by 662
“The lipid composition of the membrane of human BMECs is ∼33% phosphatidyl choline (PC), 25% phosphatidyl ethanolamine (PE), 17% sphyngomyelin (Sph), 11% phosphatidyl serine (PS), 4.8% phosphatidyl inositol (PI; Siakotos et al., 1969; Tewes and Galla, 2001).”
BackgroundInfluentialProgress and perspectives on targeting nanoparticles for brain drug delivery
Gao, H. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.05.013 · Cited by 495
Metadata
- Authors
- Pardridge, W. M.
- Venue
- Pharmaceutical Research
- Published
- 2007-06-07
- Volume
- 24
- Issue
- 9
- Pages
- 1733-1744
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W2055233461
- Cited by
- 447
- References
- 208
- FWCI
- 15.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.